A negative feedback system between brain serotonin systems and plasma active ghrelin levels in mice. 2006

Katsunori Nonogaki, and Kana Ohashi-Nozue, and Yoshitomo Oka
Center of Excellence, Division of Molecular Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Japan. knonogaki-tky@umin.ac.jp

Brain serotonin (5-hydroxytryptamine; 5-HT) systems contribute to regulate eating behavior and energy homeostasis. 5-HT2C receptors and 5-HT1B receptors have been shown to mediate anorexic effects of 5-HT drugs such as d-fenfluramine, which stimulates 5-HT release and inhibits 5-HT reuptake, and m-chlorophenylpiperazine (mCPP), a 5-HT2C receptor agonist. Here, we report that 24-h fasting increased the expression of hypothalamic 5-HT2C receptor and 5-HT1B receptor genes in association with increases in plasma active ghrelin levels compared with fed state in mice. Treatment with mCPP or fenfluramine significantly inhibited the increases in plasma active ghrelin levels. mCPP or fenfluramine significantly increased the expression of hypothalamic pro-opiomelanocortin and cocaine- and amphetamine-regulated transcript genes while having no significant effects on the expression of hypothalamic neuropeptide Y, agouti- related protein, and ghrelin genes. These results suggest that there is a negative feedback system between brain 5-HT systems and plasma active ghrelin levels in energy homeostasis in mice.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005277 Fenfluramine A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release. Fintepla,Fenfluramine Hydrochloride,Fenfluramine Hydrochloride, (+-)-Isomer,Fenfluramine Hydrochloride, R-Isomer,Fenfluramine, (+-)-Isomer,Fenfluramine, R-Isomer,Isomeride,Pondimin,Fenfluramine Hydrochloride, R Isomer,Fenfluramine, R Isomer,Hydrochloride, Fenfluramine
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000821 Animal Feed Foodstuff used especially for domestic and laboratory animals, or livestock. Fodder,Animal Feeds,Feed, Animal,Feeds, Animal,Fodders

Related Publications

Katsunori Nonogaki, and Kana Ohashi-Nozue, and Yoshitomo Oka
January 2008, Vitamins and hormones,
Katsunori Nonogaki, and Kana Ohashi-Nozue, and Yoshitomo Oka
January 1985, Experientia,
Katsunori Nonogaki, and Kana Ohashi-Nozue, and Yoshitomo Oka
October 1972, The Journal of endocrinology,
Katsunori Nonogaki, and Kana Ohashi-Nozue, and Yoshitomo Oka
January 2013, ISRN endocrinology,
Katsunori Nonogaki, and Kana Ohashi-Nozue, and Yoshitomo Oka
March 1976, Journal of neurochemistry,
Katsunori Nonogaki, and Kana Ohashi-Nozue, and Yoshitomo Oka
January 2019, Journal of oleo science,
Katsunori Nonogaki, and Kana Ohashi-Nozue, and Yoshitomo Oka
May 2005, The Journal of clinical endocrinology and metabolism,
Katsunori Nonogaki, and Kana Ohashi-Nozue, and Yoshitomo Oka
January 2006, Physiological research,
Katsunori Nonogaki, and Kana Ohashi-Nozue, and Yoshitomo Oka
March 2012, Addiction biology,
Katsunori Nonogaki, and Kana Ohashi-Nozue, and Yoshitomo Oka
January 2011, Hepato-gastroenterology,
Copied contents to your clipboard!